Clinical Trials on Pulmonary Fibrosis in New Zealand
Total 1673 results
-
InSilico Medicine Hong Kong LimitedCompletedA Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy SubjectsIdiopathic Pulmonary FibrosisNew Zealand
-
Arrowhead PharmaceuticalsRecruitingIdiopathic Pulmonary FibrosisDenmark, New Zealand, Spain
-
Algernon PharmaceuticalsCompletedIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
Biosplice Therapeutics, Inc.WithdrawnIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
Arrowhead PharmaceuticalsTerminatedCystic Fibrosis, PulmonaryAustralia, New Zealand
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPDNew Zealand
-
Pliant Therapeutics, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States, Belgium, Australia, Netherlands, Canada, Italy, New Zealand
-
Mylan Inc.Theravance BiopharmaCompleted
-
Middlemore Hospital, New ZealandUnknownPulmonary Parenchymal LesionsNew Zealand
-
Waikato HospitalWaikato Hospital Research FundCompletedChronic Obstructive Pulmonary DiseaseNew Zealand
-
University of Auckland, New ZealandTerminatedSmoking Cessation | Chronic Obstructive Pulmonary DiseaseNew Zealand
-
National Jewish HealthYale University; Icahn School of Medicine at Mount Sinai; AstraZeneca; Baylor University and other collaboratorsActive, not recruitingIdiopathic Pulmonary Fibrosis (IPF)United States
-
Bristol-Myers SquibbCompletedHealthy Participants | Idiopathic Pulmonary Fibrosis (IPF)United States
-
ReCode TherapeuticsRecruitingCystic FibrosisNew Zealand
-
Arcturus Therapeutics, Inc.Novotech CRORecruiting
-
FibroGenCompletedIdiopathic Pulmonary FibrosisUnited States, New Zealand, India, South Africa, Australia, Bulgaria, Canada
-
NYU Langone HealthStony Brook University; National Center for Research Resources (NCRR); Philips...CompletedPulmonary FibrosisUnited States
-
NYU Langone HealthWithdrawnIdiopathic Pulmonary FibrosisUnited States
-
HuniLife Biotechnology, Inc.RecruitingIdiopathic Pulmonary FibrosisTaiwan
-
University of OtagoHealth Research Council, New ZealandCompleted
-
Fisher and Paykel HealthcareMedical Research Institute of New Zealand; Alana HealthcareTerminatedChronic Obstructive Pulmonary Disease | COPDUnited States, New Zealand
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI); University of Chicago; Columbia... and other collaboratorsCompletedIdiopathic Pulmonary FibrosisUnited States
-
BiogenCompletedIdiopathic Pulmonary Fibrosis (IPF)United States
-
FibroGenCompletedIdiopathic Pulmonary FibrosisUnited States
-
Galapagos NVTerminatedIdiopathic Pulmonary FibrosisUnited States, Netherlands, Korea, Republic of, Israel, Japan, New Zealand, France, Italy, Argentina, Germany, Hungary, South Africa, Poland, Canada, Mexico
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of Iowa; Weill... and other collaboratorsCompletedIdiopathic Pulmonary Fibrosis | Interstitial Lung DiseaseUnited States
-
Hal ChapmanMassachusetts General Hospital; University of Michigan; University of Washington and other collaboratorsRecruitingIdiopathic Pulmonary FibrosisUnited States
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); Duke Clinical Research InstituteTerminatedIdiopathic Pulmonary FibrosisUnited States
-
GlaxoSmithKlineCompleted
-
Bristol-Myers SquibbCompletedIdiopathic Pulmonary FibrosisUnited States, Mexico, Australia, Colombia, Chile, Peru
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Germany
-
ActelionCompletedPulmonary Fibrosis | Pulmonary HypertensionUnited States
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); PfizerCompletedPulmonary Fibrosis | Hypertension, PulmonaryUnited States
-
Novartis PharmaceuticalsCompleted
-
Cystetic Medicines, Inc.DevPro BiopharmaRecruitingCystic FibrosisAustralia, New Zealand
-
VenitiWithdrawnDeep Vein Thrombosis | Pulmonary EmbolusNew Zealand, Australia
-
Duke UniversityBoehringer IngelheimRecruitingIdiopathic Pulmonary Fibrosis, Interstitial Lung DiseaseUnited States, Puerto Rico
-
University of Alabama at BirminghamUniversity of Michigan; Tulane University; Temple UniversityRecruitingIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Canada, Turkey
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of Chicago; University... and other collaboratorsTerminatedIdiopathic Pulmonary FibrosisUnited States
-
Genentech, Inc.CompletedIdiopathic Pulmonary Fibrosis | Pulmonary FibrosisUnited States
-
Cumberland PharmaceuticalsRecruitingIdiopathic Pulmonary FibrosisUnited States
-
Gilead SciencesTerminatedIdiopathic Pulmonary Fibrosis | Pulmonary HypertensionUnited States, Germany, United Kingdom, Australia, Canada, Italy, Austria
-
Geno LLCCompletedIdiopathic Pulmonary Fibrosis | Pulmonary Arterial HypertensionUnited States
-
ImmuneWorksCompletedIdiopathic Pulmonary FibrosisUnited States
-
Pulmonary Fibrosis FoundationUniversity of MichiganCompletedInterstitial Lung Disease (ILD) | Idiopathic Pulmonary Fibrosis (IPF)United States
-
Pliant Therapeutics, Inc.RecruitingIdiopathic Pulmonary FibrosisUnited States, Australia, Taiwan, Korea, Republic of, Portugal, Germany, Israel, Denmark, New Zealand, Netherlands, Canada, Chile, Czechia, France, Greece, Italy, Poland
-
Boehringer IngelheimActive, not recruiting
-
Lassen Therapeutics 1 PTY LTDRecruitingThyroid Eye Disease | Pulmonary FibrosisAustralia, Hong Kong, New Zealand
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, New Zealand